Czechia vs South Korea: Cause of death, by non-communicable diseases, ages 15-59, male
Czechia
65.9%
in 2021
South Korea
66.6%
in 2021
Czechia rank
42nd
South Korea rank
41st
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Czechia
- South Korea
How they compare
South Korea currently reports 66.6% against 65.9% in Czechia, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Czechia ahead.
Czechia ranks 42nd and South Korea ranks 41st of 185 countries.
Czechia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Czechia | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.4% | 66.7% | 7.7% | Czechia |
| 2010s | 74.4% | 65.9% | 8.5% | Czechia |
| 2020s | 69.4% | 67.1% | 2.3% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Czechia or South Korea?
- South Korea, at 66.6% against 65.9% in Czechia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Czechia and South Korea?
- 0.7%, with South Korea ahead.
- How many years of comparable data are there for Czechia and South Korea?
- 6 years are reported by both, from 2000 to 2021.
- How do Czechia and South Korea rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Czechia ranks 42nd and South Korea ranks 41st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.